findmyKOL

Peter Kaiser, MD

Enriched profile

Chaney Family Endowed Chair in Ophthalmology Research; Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine; Staff, Vitreoretinal Faculty, Cole Eye Institute · Cole Eye Institute

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2005–2006

Peter Kaiser is Chaney Family Endowed Chair in Ophthalmology Research; Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine; Staff, Vitreoretinal Faculty, Cole Eye Institute at Cole Eye Institute. OpenAlex indexes 770 publications with 40,088 citations (h-index 82); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Ophthalmology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 15 Oct 2026

Peter Kaiser, MD, is Chaney Family Endowed Chair in Ophthalmology Research at Cole Eye Institute, Cleveland Clinic. The public record shows 770 publications with 40,088 citations (h-index 82), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Retinal Imaging and Analysis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 38 companies, 1 NIH-funded awards (2005–2006).

  • Most recent indexed publication: 2026 · Journal of vitreoretinal diseases
  • Top research focus: Retinal Diseases and Treatments
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 38 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)1 trialDiabetic Complications1 trialDiabetic Retinopathy / DME1 trialDiabetic Retinopathy1 trialMultiple Sclerosis1 trialOptic Neuritis1 trialNeuritis1 trialCardiovascular Diseases1 trialPeripheral Arterial Disease1 trialThrombosis1 trialVascular Diseases1 trialEdema1 trialLymphedema1 trialAneurysm1 trialVasculitis1 trialSpasm1 trialLipedema1 trialThoracic Outlet Syndrome1 trialMay-Thurner Syndrome1 trialFibromuscular Dysplasia1 trialDissection, Blood Vessel1 trialChoroidal Neovascularization1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal and Macular SurgeryRetinal Imaging and AnalysisOcular Diseases and Behçet’s SyndromeRetinal and Optic Conditions

Drugs & molecules

across trials, industry payments and publications
Eyleageneric · AfliberceptClinical trials—Industry payments31Publications8Beovugeneric · BrolucizumabClinical trials—Industry payments14Publications4Cimerligeneric · RanibizumabClinical trials—Industry payments11Publications7Izervaygeneric · Avacincaptad pegolClinical trials—Industry payments11Publications1Xiperegeneric · TriamcinoloneClinical trials—Industry payments1Publications1Ozurdexgeneric · DexamethasoneClinical trials—Industry payments34Publications—EYLEA HDClinical trials—Industry payments21Publications—Lumakrasgeneric · SotorasibClinical trials—Industry payments2Publications—Sodium ascorbateClinical trials—Industry payments2Publications—Miebogeneric · PerfluorohexyloctaneClinical trials—Industry payments1Publications—Udenycageneric · PegfilgrastimClinical trials—Industry payments1Publications—Vabysmogeneric · FaricimabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments32Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments27Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments27Boehringer Ingelheim International GmbHClinical trials—Industry payments17Ocular Therapeutix, Inc.Clinical trials—Industry payments14Merck Sharp & Dohme LLCClinical trials—Industry payments11Novartis Pharma AGClinical trials—Industry payments11Coherus Biosciences Inc.Clinical trials—Industry payments9Astellas Pharma US IncClinical trials—Industry payments8Allergan, Inc.Clinical trials—Industry payments7Bausch & Lomb Americas Inc.Clinical trials—Industry payments7Alcon Research LLCClinical trials—Industry payments6Astellas Pharma Global DevelopmentClinical trials—Industry payments5Genentech USA, Inc.Clinical trials—Industry payments5Janssen Global Services, LLCClinical trials—Industry payments5Samsung Bioepis Co., Ltd.Clinical trials—Industry payments5Alcon Vision LLCClinical trials—Industry payments4Biogen, Inc.Clinical trials—Industry payments4Novartis Pharmaceuticals CorporationClinical trials—Industry payments4Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments2Amgen Inc.Clinical trials—Industry payments2Carl Zeiss Meditec, Inc.Clinical trials—Industry payments2Eli Lilly and CompanyClinical trials—Industry payments2EyePoint Pharmaceuticals US, Inc.Clinical trials—Industry payments2Hexal AGClinical trials—Industry payments2Sanofi Us Services Inc.Clinical trials—Industry payments2The Cleveland ClinicClinical trials2Industry payments—Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments1Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments1Astellas Pharma Europe LtdClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
770publications

Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.

40,088citations

Total citations across indexed works.

82h-index

Hirsch index (OpenAlex). i10-index 343.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
38companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2005–2006

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

38 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    80.4%
    alpha-Adrenergic Agonist20.7%
    Brimonidine Tartrate100%
    Part D<11 patients
    Corticosteroid16.3%
    Prednisolone Acetate100%
    Part D<11 patients

    + 3 more classes in this area

  • Musculoskeletal

    19.6%
    Cyclooxygenase Inhibitor19.6%
    Ketorolac Tromethamine100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 15 Oct 2026

1 NIH research award on record, funded 2005–2006 per NIH RePORTER. The latest:

All 59 award records: search, sort and filter.Explore →

Congress activity

Updated 15 Oct 2026

1 congress contribution (2023) across ADA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Rishi P. Singh104Justis P. Ehlers94Sunil K. Srivastava83Jeffrey S. Heier47Jonathan E. Sears45Sumit Sharma44Sophie J. Bakri44Frank G. Holz41Aleksandra Rachitskaya41Charles C. Wykoff40Sobha Sivaprasad36Careen Y. Lowder36Varun Chaudhary34Sunir J. Garg33David S. Boyer33Neil J. Friedman30Andrew Schachat30David Sarraf29Mark Phillips29Alex Yuan28Lehana Thabane27Robyn H. Guymer27Darius M. Moshfeghi27Amy Babiuch25Tien Yin Wong25Arshad M. Khanani17Mohit Bhandari17Kimberly Baynes16Quan Dong Nguyen16Jamie Reese16Daniel Martín15Carl D. Regillo15Glenn J. Jaffe14Hugo Quiroz–Mercado14Jason S. Slakter13Baruch D. Kuppermann13Ron Margolis12Robert Vitti12Oswaldo Ferreira Moura Brasil12Scott D. Smith12

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/peter-kaiser-md-2e4b127b

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    asrs.org/patients/retina-health-for-life-podcast

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Founding Director

    Digital Optical Coherence Tomography (OCT) Reading Center, Cole Eye Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
  • Team ophthalmologist

    Cleveland Cavaliers (NBA)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theorg.com ↗
  • Team ophthalmologist

    Cleveland Browns (NFL) and Cleveland Guardians (MLB)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
  • Editor-in-Chief

    Retinal Physician

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗
  • Director

    Center for Ocular Research and Evaluation (CORE)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗
  • Fellow

    American Society of Retina Specialists (FASRS)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Professor of Ophthalmology

    Case Western Reserve University School of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.